Public Statements

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.

results per page:
Date Title Politician
June 11, 2008 Paxil Sen. Chuck Grassley
June 6, 2008 Letter to Andrew C. von Eschenbach, Commissioner of the FDA, Re: ProHeart 6 Back on the Market with FDA Approval Sen. Chuck Grassley
June 4, 2008 Payments to Physicians Sen. Chuck Grassley
May 30, 2008 Statement of U.S. Senator Chuck Grassley of Iowa Regarding the Guest Commentary Titled "Grassley's War on Cancer Patients" Printed in The Wall Street Journal on Thursday, May 29, 2008 Sen. Chuck Grassley
May 22, 2008 Grassley: Drug Endangered Children Act of 2007 Clears Judiciary Committee Sen. Chuck Grassley
May 22, 2008 Senators Welcome Endorsements of Physicians Payments Sunshine Act Sen. Chuck Grassley, ...
May 13, 2008 Senators Praise Growing Support for Transparency in Drug Industry Payments to Physicians Sen. Chuck Grassley, ...
May 2, 2008 Letter to Condoleeza Rice, Secretary of State, Re: Information About Connection Between Afghan National Police and Drug Money and Violence Sen. Chuck Grassley
April 21, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Off-Label Promotion of Drugs Sen. Chuck Grassley
April 9, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Implement Law Lowering Prescription Drug Prices Sen. Chuck Grassley, ...
April 7, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: JAG Funding Sen. Chuck Grassley, ...
April 3, 2008 Letter to Kevin Sharer, Chairman, and CEO and President of Amgen Inc., Re: Increased Rebates to Physicians Prescribing Anti-Anemia Drugs Sen. Chuck Grassley
April 2, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 -- Motion to Proceed Sen. Chuck Grassley
March 13, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Changes to Improve FDA Post-Market Review Remain Elusive Sen. Chuck Grassley
March 13, 2008 Grassley Comments on FDA Advisory Committee Recommendations for Anti-Anemia Drugs Sen. Chuck Grassley
March 11, 2008 Letter to Michael Leavitt, Secretary of Health and Human Services, and Andrew von Eschenbach, Commissioner of the FDA, Re: Registration Fees for Inspection of Foreign Manufacturers of Pharmaceutical Drugs Sen. Chuck Grassley
March 4, 2008 Grassley Secures Independent Review of FDA Approvals Based on Narrow Health Benefits Sen. Chuck Grassley
Feb. 28, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Information About Foreign Inspections, Drug Safety Sen. Chuck Grassley
Feb. 21, 2008 Finance Leaders Aim to Help Seniors Seeking Addional Coverage From Medicare Drug Benefit Plans Sen. Chuck Grassley, ...
Feb. 14, 2008 Grassley Says Hold on Imported Blood Thinner Component Underscores Questions About FDA Foreign Inspections Sen. Chuck Grassley
Feb. 12, 2008 Letter to Fred Hassan, Chairman of the Board, Chief Executive Officer of the Schering-Plough Corporation, Re: Questions About Statements Regarding Drug Trial Sen. Chuck Grassley
Feb. 6, 2008 Letter to Christopher Viehbacher, President of GlaxoSmithKline, Re: Request for Key Documents Relating to Paxil Sen. Chuck Grassley
Jan. 30, 2008 Drug Safety Sen. Chuck Grassley
Jan. 11, 2008 Baucus, Grassley Comment on Report on Medicare Drug Benefit Payments to Community Pharmacies Sen. Chuck Grassley, ...
Dec. 20, 2007 Grassley Releases More Findings on FDA's Handling of Ketek Safety Sen. Chuck Grassley
Date Title Politician
June 11, 2008 Paxil Sen.Chuck Grassley
June 6, 2008 Letter to Andrew C. von Eschenbach, Commissioner of the FDA, Re: ProHeart 6 Back on the Market with FDA Approval Sen.Chuck Grassley
June 4, 2008 Payments to Physicians Sen.Chuck Grassley
May 30, 2008 Statement of U.S. Senator Chuck Grassley of Iowa Regarding the Guest Commentary Titled "Grassley's War on Cancer Patients" Printed in The Wall Street Journal on Thursday, May 29, 2008 Sen.Chuck Grassley
May 22, 2008 Grassley: Drug Endangered Children Act of 2007 Clears Judiciary Committee Sen.Chuck Grassley
May 22, 2008 Senators Welcome Endorsements of Physicians Payments Sunshine Act Sen.Chuck Grassley, ...
May 13, 2008 Senators Praise Growing Support for Transparency in Drug Industry Payments to Physicians Sen.Chuck Grassley, ...
May 2, 2008 Letter to Condoleeza Rice, Secretary of State, Re: Information About Connection Between Afghan National Police and Drug Money and Violence Sen.Chuck Grassley
April 21, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Off-Label Promotion of Drugs Sen.Chuck Grassley
April 9, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Implement Law Lowering Prescription Drug Prices Sen.Chuck Grassley, ...
April 7, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: JAG Funding Sen.Chuck Grassley, ...
April 3, 2008 Letter to Kevin Sharer, Chairman, and CEO and President of Amgen Inc., Re: Increased Rebates to Physicians Prescribing Anti-Anemia Drugs Sen.Chuck Grassley
April 2, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 -- Motion to Proceed Sen.Chuck Grassley
March 13, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Changes to Improve FDA Post-Market Review Remain Elusive Sen.Chuck Grassley
March 13, 2008 Grassley Comments on FDA Advisory Committee Recommendations for Anti-Anemia Drugs Sen.Chuck Grassley
March 11, 2008 Letter to Michael Leavitt, Secretary of Health and Human Services, and Andrew von Eschenbach, Commissioner of the FDA, Re: Registration Fees for Inspection of Foreign Manufacturers of Pharmaceutical Drugs Sen.Chuck Grassley
March 4, 2008 Grassley Secures Independent Review of FDA Approvals Based on Narrow Health Benefits Sen.Chuck Grassley
Feb. 28, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Information About Foreign Inspections, Drug Safety Sen.Chuck Grassley
Feb. 21, 2008 Finance Leaders Aim to Help Seniors Seeking Addional Coverage From Medicare Drug Benefit Plans Sen.Chuck Grassley, ...
Feb. 14, 2008 Grassley Says Hold on Imported Blood Thinner Component Underscores Questions About FDA Foreign Inspections Sen.Chuck Grassley
Feb. 12, 2008 Letter to Fred Hassan, Chairman of the Board, Chief Executive Officer of the Schering-Plough Corporation, Re: Questions About Statements Regarding Drug Trial Sen.Chuck Grassley
Feb. 6, 2008 Letter to Christopher Viehbacher, President of GlaxoSmithKline, Re: Request for Key Documents Relating to Paxil Sen.Chuck Grassley
Jan. 30, 2008 Drug Safety Sen.Chuck Grassley
Jan. 11, 2008 Baucus, Grassley Comment on Report on Medicare Drug Benefit Payments to Community Pharmacies Sen.Chuck Grassley, ...
Dec. 20, 2007 Grassley Releases More Findings on FDA's Handling of Ketek Safety Sen.Chuck Grassley
arrow_upward